启明创投

@author-1788515151757110

258 articles

Articles

Qiming Venture Partners Portfolio Companies Showcase Innovations at World Robot Conference 2025

Qiming Venture Partners Portfolio Companies Showcase Innovations at World Robot Conference 2025

World Robot Conference 2025 will center on the theme "Making Robots Smarter, Making Embodied Intelligence More Intelligent," focusing on expanding application scenarios, frontier technological innovation, breakthroughs in key technologies, new product launches, and international cooperation. It will showcase the latest scientific research achievements, application products, and solutions from the global robotics field.

Qiming Venture Partners Portfolio Founders Named to Wealth China 40 Under 40 Business Elite Lists

Qiming Venture Partners Portfolio Founders Named to Wealth China 40 Under 40 Business Elite Lists

The 40 Under 40 Business Elite list spotlights China's most influential young leaders of the moment, while the 40 Under 40 Most Promising Business Elite list selects the most promising innovators across industries. These are the young people driving change in Chinese business — and shaping the world.

Dialogue | William Hu and Insilico Medicine's Ren Feng on How AI Is Driving Next-Generation Drug Discovery

Dialogue | William Hu and Insilico Medicine's Ren Feng on How AI Is Driving Next-Generation Drug Discovery

For AI drug discovery companies, it's not enough to possess proprietary core technologies — they must also embed themselves deeply into the practical scenarios of pharmaceutical R&D, driving those technologies toward real-world implementation and commercial translation.

Qiming Venture Partners' Portfolio Company WeRide Kicks Off 24/7 Stress Testing in Beijing

Qiming Venture Partners' Portfolio Company WeRide Kicks Off 24/7 Stress Testing in Beijing

WeRide is among the first autonomous driving companies approved to conduct nighttime road tests in Beijing, marking a critical step toward building a "7×24" autonomous driving service network in the city and laying a solid foundation for truly round-the-clock autonomous mobility services.

Zenitar Raises Nearly 400 Million Yuan in B+ Round Led by Qiming Venture Partners

Zenitar Raises Nearly 400 Million Yuan in B+ Round Led by Qiming Venture Partners

Zenitar is a structure-based biology and AI-driven innovative drug R&D company, focused on unmet clinical needs in major therapeutic areas including oncology, autoimmune diseases, inflammation, and neurological disorders. The company is dedicated to discovering, developing, and commercializing first-in-class and best-in-class innovative medicines.

Evolutionary Tide Raises Hundreds of Millions of Yuan in Pre-A Round, Qiming Venture Partners Co-Leads

Evolutionary Tide Raises Hundreds of Millions of Yuan in Pre-A Round, Qiming Venture Partners Co-Leads

Emergent Tide is built on original research from the Tsinghua University School of Medicine team in the field of humoral immunity, developing novel therapeutics for inflammatory and autoimmune diseases against a first-in-class global target, addressing core challenges in the field and significant unmet clinical needs.